Physician profile

Daniel W Foster

Endocrinology, Diabetes & Metabolism · Dallas, TX

NPI 1851350987

$36.11

in general payments reported to CMS, 2019-2025

1 company · none reported in 2025

See the full distribution for Endocrinology, Diabetes & Metabolism

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Pacira Pharmaceuticals Incorporated $36.11 2020

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Daniel W Foster

$36.11

in general payments reported 2019-2025

Years
2020
Top company
Pacira Pharmaceuticals Incorporated

https://glasscript.com/doctor/1042266/daniel-w-foster

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.